{"count": 77, "results": [{"_id": "37638270", "pmid": 37638270, "pmcid": "PMC10449231", "title": "Silent Myocardial Infarction: A Case Report", "journal": "Cureus", "authors": ["Kolesova MV", "Minor S"], "date": "2023-08-22T00:00:00Z", "doi": "10.7759/cureus.43906", "meta_date_publication": "2023 Aug", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e43906", "score": 50272.48, "text_hl": "On further workup, ECG revealed low voltage QRS complexes, flat QRS complexes, flat T waves, and pathological Q waves, suggesting the diagnosis of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@SMI@@@. Based on the identified risk factors, including high BMI, @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@, primary @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@, @DISEASE_Herpes_Zoster @DISEASE_MESH:D006562 @@@HZ@@@, and newly diagnosed @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@SMI@@@, the @SPECIES_9606 @@@patient@@@ was advised to continue with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ 20 mg daily, prescribed @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ 80 mg daily, and was educated about maintaining a healthy diet, exercise, and receiving the shingles vaccination. ", "citations": {"NLM": "Kolesova MV, Minor S. Silent Myocardial Infarction: A Case Report Cureus. 2023 Aug;15(8):e43906. PMID: 37638270", "BibTeX": "@article{37638270, title={Silent Myocardial Infarction: A Case Report}, author={Kolesova MV and Minor S}, journal={Cureus}, volume={15}, number={8}, pages={e43906}}"}}, {"_id": "32073735", "pmid": 32073735, "pmcid": "PMC7171409", "title": "Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells", "journal": "J Cell Mol Med", "authors": ["Ma Y", "Ma L", "Ma J", "Wu R", "Zou Y", "Ge J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1111/jcmm.15060", "meta_date_publication": "2020 Apr", "meta_volume": "24", "meta_issue": "7", "meta_pages": "4082-4091", "score": 50268.027, "text_hl": "@DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@Hyperlipidemia@@@ inhibits the protective effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ via activation of dendritic cells", "citations": {"NLM": "Ma Y, Ma L, Ma J, Wu R, Zou Y, Ge J. Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells J Cell Mol Med. 2020 Apr;24(7):4082-4091. PMID: 32073735", "BibTeX": "@article{32073735, title={Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells}, author={Ma Y and Ma L and Ma J and Wu R and Zou Y and Ge J}, journal={J Cell Mol Med}, volume={24}, number={7}, pages={4082-4091}}"}}, {"_id": "31977576", "pmid": 31977576, "title": "The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.", "journal": "J Hypertens", "authors": ["Juraschek SP", "Simpson LM", "Davis BR", "Shmerling RH", "Beach JL", "Ishak A", "Mukamal KJ"], "date": "2020-05-01T00:00:00Z", "doi": "10.1097/HJH.0000000000002359", "meta_date_publication": "2020 May", "meta_volume": "38", "meta_issue": "5", "meta_pages": "954-960", "score": 50253.992, "text_hl": "METHODS: The Antihypertensive and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@-Lowering Treatment to Prevent @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@Heart Attack@@@ Trial (ALLHAT) was a randomized clinical trial on the effects of first-step @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ therapy with @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on fatal @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@ or nonfatal @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (1994-2002). ", "citations": {"NLM": "Juraschek SP, Simpson LM, Davis BR, Shmerling RH, Beach JL, Ishak A, Mukamal KJ. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Hypertens. 2020 May;38(5):954-960. PMID: 31977576", "BibTeX": "@article{31977576, title={The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.}, author={Juraschek SP and Simpson LM and Davis BR and Shmerling RH and Beach JL and Ishak A and Mukamal KJ}, journal={J Hypertens}, volume={38}, number={5}, pages={954-960}}"}}, {"_id": "33550755", "pmid": 33550755, "title": "[The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.]", "journal": "Adv Gerontol", "authors": ["Agarkov NM", "Proschayev KI", "Lutay YA", "Ilnitskiy AN", "Korneeva SI", "Markelova AM", "Kolomiets VI"], "date": "2020-01-01T00:00:00Z", "meta_date_publication": "2020", "meta_volume": "33", "meta_issue": "5", "meta_pages": "972-976", "score": 50253.586, "text_hl": "In 62 @SPECIES_9606 @@@patients@@@ with a history of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ at the age of 60-74, a fixed combination of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ at a dose of 5/10/10 mg 2 hours before reaching maximum systolic blood pressure (preventive chronotherapy), in 63 @SPECIES_9606 @@@patients@@@ with similar diseases and age, this drug is taken at a dose of 5/10/10mg in the evening, and in 58 people - in the morning (traditional treatment). ", "citations": {"NLM": "Agarkov NM, Proschayev KI, Lutay YA, Ilnitskiy AN, Korneeva SI, Markelova AM, Kolomiets VI. [The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.] Adv Gerontol. 2020;33(5):972-976. PMID: 33550755", "BibTeX": "@article{33550755, title={[The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.]}, author={Agarkov NM and Proschayev KI and Lutay YA and Ilnitskiy AN and Korneeva SI and Markelova AM and Kolomiets VI}, journal={Adv Gerontol}, volume={33}, number={5}, pages={972-976}}"}}, {"_id": "36376029", "pmid": 36376029, "title": "Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.", "journal": "J Biomol Struct Dyn", "authors": ["Atiya A", "Alsayari A", "Bin Muhsinah A", "Almaghaslah D", "Bilgrami AL", "Abdulmonem WA", "Alorfi NM", "DasGupta D", "Ashraf GM", "Shamsi A", "Shahwan M"], "date": "2022-11-14T00:00:00Z", "doi": "10.1080/07391102.2022.2143425", "meta_date_publication": "2022 Nov 14", "meta_volume": "", "meta_issue": "", "meta_pages": "1-7", "score": 50252.63, "text_hl": "This is also used to treat @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@, which plays a vital role in improving the survival rate post-@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@heart attack@@@. In this study, we will evaluate the @GENE_MARK4 @GENE_57787 @@@MARK4@@@ inhibitory potential of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ employing molecular docking and molecular dynamics (MD) simulation approaches. ", "citations": {"NLM": "Atiya A, Alsayari A, Bin Muhsinah A, Almaghaslah D, Bilgrami AL, Abdulmonem WA, Alorfi NM, DasGupta D, Ashraf GM, Shamsi A, Shahwan M. Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches. J Biomol Struct Dyn. 2022 Nov 14;():1-7. PMID: 36376029", "BibTeX": "@article{36376029, title={Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.}, author={Atiya A and Alsayari A and Bin Muhsinah A and Almaghaslah D and Bilgrami AL and Abdulmonem WA and Alorfi NM and DasGupta D and Ashraf GM and Shamsi A and Shahwan M}, journal={J Biomol Struct Dyn}, pages={1-7}}"}}, {"_id": "34674811", "pmid": 34674811, "title": "Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.", "journal": "J Am Coll Cardiol", "authors": ["Itoga NK", "Tawfik DS", "Montez-Rath ME", "Chang TI"], "date": "2021-10-26T00:00:00Z", "doi": "10.1016/j.jacc.2021.08.035", "meta_date_publication": "2021 Oct 26", "meta_volume": "78", "meta_issue": "17", "meta_pages": "1671-1678", "score": 50234.816, "text_hl": "METHODS: This study analyzed ALLHAT (Antihypertensive and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@-Lowering Treatment to Prevent @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@Heart Attack@@@ Trial) data, which randomized adults to @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Itoga NK, Tawfik DS, Montez-Rath ME, Chang TI. Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study. J Am Coll Cardiol. 2021 Oct 26;78(17):1671-1678. PMID: 34674811", "BibTeX": "@article{34674811, title={Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.}, author={Itoga NK and Tawfik DS and Montez-Rath ME and Chang TI}, journal={J Am Coll Cardiol}, volume={78}, number={17}, pages={1671-1678}}"}}, {"_id": "9435355", "pmid": 9435355, "title": "[Effect of lisinopril on cardiac parameters and mortality after myocardial infarction in rats].", "journal": "Arq Bras Cardiol", "authors": ["Zornoff LA", "Paiva SA", "Matsubara BB", "Matsubara LS", "Tucci PJ", "Spadaro J"], "date": "1997-03-01T00:00:00Z", "meta_date_publication": "1997 Mar", "meta_volume": "68", "meta_issue": "3", "meta_pages": "175-9", "score": 50075.312, "text_hl": "[Effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on cardiac parameters and mortality after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ in @SPECIES_10116 @@@rats@@@].", "citations": {"NLM": "Zornoff LA, Paiva SA, Matsubara BB, Matsubara LS, Tucci PJ, Spadaro J. [Effect of lisinopril on cardiac parameters and mortality after myocardial infarction in rats]. Arq Bras Cardiol. 1997 Mar;68(3):175-9. PMID: 9435355", "BibTeX": "@article{9435355, title={[Effect of lisinopril on cardiac parameters and mortality after myocardial infarction in rats].}, author={Zornoff LA and Paiva SA and Matsubara BB and Matsubara LS and Tucci PJ and Spadaro J}, journal={Arq Bras Cardiol}, volume={68}, number={3}, pages={175-9}}"}}, {"_id": "10879622", "pmid": 10879622, "title": "Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats.", "journal": "Basic Res Cardiol", "authors": ["Zornoff LA", "Matsubara BB", "Matsubara LS", "Paiva SA", "Spadaro J"], "date": "2000-06-01T00:00:00Z", "doi": "10.1007/s003950050183", "meta_date_publication": "2000 Jun", "meta_volume": "95", "meta_issue": "3", "meta_pages": "208-14", "score": 50072.277, "text_hl": "Early rather than delayed administration of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ protects the heart after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Zornoff LA, Matsubara BB, Matsubara LS, Paiva SA, Spadaro J. Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res Cardiol. 2000 Jun;95(3):208-14. PMID: 10879622", "BibTeX": "@article{10879622, title={Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats.}, author={Zornoff LA and Matsubara BB and Matsubara LS and Paiva SA and Spadaro J}, journal={Basic Res Cardiol}, volume={95}, number={3}, pages={208-14}}"}}, {"_id": "8891468", "pmid": 8891468, "title": "Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.", "journal": "Drugs", "authors": ["Goa KL", "Balfour JA", "Zuanetti G"], "date": "1996-10-01T00:00:00Z", "doi": "10.2165/00003495-199652040-00011", "meta_date_publication": "1996 Oct", "meta_volume": "52", "meta_issue": "4", "meta_pages": "564-88", "score": 50072.27, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@. A review of its pharmacology and clinical efficacy in the early management of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@.", "citations": {"NLM": "Goa KL, Balfour JA, Zuanetti G. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction. Drugs. 1996 Oct;52(4):564-88. PMID: 8891468", "BibTeX": "@article{8891468, title={Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.}, author={Goa KL and Balfour JA and Zuanetti G}, journal={Drugs}, volume={52}, number={4}, pages={564-88}}"}}, {"_id": "14754654", "pmid": 14754654, "title": "Pemphigus foliaceus: an adverse reaction to lisinopril.", "journal": "J Dermatolog Treat", "authors": ["Patterson CR", "Davies MG"], "date": "2004-01-01T00:00:00Z", "doi": "10.1080/09546630310013379", "meta_date_publication": "2004 Jan", "meta_volume": "15", "meta_issue": "1", "meta_pages": "60-2", "score": 50070.57, "text_hl": "We report a case of @DISEASE_Pemphigus @DISEASE_MESH:D010392 @@@pemphigus foliaceus@@@ in a 66-year-old male treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ for @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and a previous @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@. ", "citations": {"NLM": "Patterson CR, Davies MG. Pemphigus foliaceus: an adverse reaction to lisinopril. J Dermatolog Treat. 2004 Jan;15(1):60-2. PMID: 14754654", "BibTeX": "@article{14754654, title={Pemphigus foliaceus: an adverse reaction to lisinopril.}, author={Patterson CR and Davies MG}, journal={J Dermatolog Treat}, volume={15}, number={1}, pages={60-2}}"}}]}